Volume 91, issue 4, Avril 2004

ÉDITORIAL

Le cancer du sein, paradigme cancérologique (p.203)
Jean‐Philippe Spano, Paul‐Henri Cottu

Introducing the Electronic Journal of Oncology (p.297)
Philippe Jeanteur, Charles Dumontet

La recherche est‐elle sauvée ? (p.299)
Philippe Jeanteur

Brèves

Les récepteurs membranaires empruntent un chemin détourné menant au cancer (p.300)
Fabien Alpy, Carole Mathelin
Open Access

L’inhibiteur d’Aurora kinases VX680, chef de file d’une nouvelle famille d’agents antitumoraux (p.300)
François Lavelle
Open Access

Le gène Ovca1, délété dans le cancer de l’ovaire, est un suppresseur de tumeurs particulier (p.300-1)
Gilles L’Allemain
Open Access

Synthèse

Classification of preinvasive breast and carcinoma in situ : doubts, controversies, and proposal for new categorizations (p.205-10)
Marie-Mélanie Dauplat, Frédérique Penault-Llorca

Assessment of HER2 status in breast cancer (p.211-5)
Frédérique Penault-Llorca, Anne Cayre

What is new about sentinel lymph node biopsy in breast cancer? (p.216-20)
Gilles Houvenaeghel, Max Buttarelli, Isabelle Rossi, Agnès Tallet, Jocelyne Jacquemier, Patrice Viens

Sentinel lymph node negative breast cancer larger than 30 mm : is axillary lymph node dissection constantly necessary ? (p.221-5)
Gilles Houvenaeghel, Marc Martino, Max Buttarelli, Vincent Moutardier, Emmanuelle Charaffe Jaufret, Isabelle Rossi, Carole Tarpin, Agnès Tallet, Patrice Viens, Jocelyne Jacquemier

Breast carcinoma and genomic technology: contribution of DNA microarrays (p.226-31)
Nicolas Sévenet, Paul-Henri Cottu

Neoadjuvant treatment of early breast cancer: new drugs contribution (p.232-8)
Sylvie Giacchetti, Caroline Cuvier, Hamid Hocini, Edwige Bourstyn, Anne de Roquancourt, Marc Espié

Aromatase inhibitors in adjuvant setting in breast cancer (p.239-43)
Jean-Philippe Spano, David Khayat, Thierry Delozier

Dose density and dose intensity in the treatment of breast cancer (p.244-53)
Pierre Saintigny, Sabine Assouad, Joseph Gligorov, Frédéric Selle, Henri Roché, Jean-Luc Breau, Jean-François Morère, Jean-Pierre Lotz

Expression of chemokine receptors by cancer cells (p.254-6)
Fabrice André, Jean-Charles Soria, H Assi, Suzy Delaloge, Michel Spielmann

Targeted therapies: last focus on EGF receptor inhibitors in breast cancer (p.257-60)
Nicolas Magné, Gérard Milano

Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colorectal and endometrial adenocarcinomas (p.303-15)
Sylviane Olschwang, Catherine Bonaïti, Josué Feingold, Thierry Frébourg, Sophie Grandjouan, Christine Lasset, Pierre Laurent‐Puig, Fabrice Lecuru, Bertrand Millat, Hagay Sobol, Gilles Thomas, François Eisinger

From cytogenetics to cytogenomics of adipose tissue tumors 2. Malignant adipose tissue tumors (p.317-23)
Florence Pedeutour, Georges Maire, Nicolas Sirvent, Groupe francophone de cytogénétique oncologique

PTPL1, a proapoptotic protein tyrosine phosphatase in breast cancers (p.325-32)
Gilles Freiss, Guillaume Bompard, Françoise Vignon

Brain metastases: a neurosurgical point of view (p.333-7)
Pierre Kehrli, Mireille Moumi

Treatment of hot flashes in women with a previous diagnosis of breast cancer (p.339-49)
Philippe Debourdeau, Thomas Bachelot, Christine Zammit, Marc Aletti, Cyrille Gallineau, Joseph Gligorov

SOR

An evidence‐based patient information and patient education programme: the SOR SAVOIR PATIENT (p.351-3)
Julien Carretier, Line Leichtnam‐Dugarin, Valérie Delavigne, Sylvie Brusco, Thierry Philip, Béatrice Fervers, Comité d’organisation des SOR

Comprendre l’examen d’imagerie par résonance magnétique (IRM) (p.355-7)

Comprendre le scanner (p.359-61)

Article original

Larynx cancer in France: descriptive epidemiology and incidence estimation (p.363-8)
Jun Peng, François Ménégoz, Josette Mace Lesec’h, Laurent Remontet, Pascale Grosclaude, Antoine Buémi, Anne‐Valérie Guizard, Brigitte Tretarre, Arlette Danzon, Michel Velten, Nabil Maarouf, Éric Jougla, Guy Launoy, Alain Dubreuil

Contribution of serum Cyfra 21‐1 in nasopharyngeal carcinoma in Tunisia (p.369-72)
Aouatef Jmal, Hamouda Boussen, Monia Abdennebi, Sonia Gara, Latifa Harzallah, Saïd Gritli, Abderrahmen Ladgham, Fethi Guemira, Abderraouf Ghanem

Identification of prognostic factors in post‐transplantation lymphoproliferative disorders (p.373-8)
Sylvain Choquet, Vincent Levy, Véronique Leblond

Sentinel lymph node biopsy in cervical and endometrial cancers: a feasibility study (p.379-84)
Loïc Lelièvre, Sophie Camatte, Marie‐Aude Le Frère‐Belda, Khaldoun Kerrou, Marc Froissart, Roland Taurelle, Françoise Vildé, Fabrice Lécuru

Electronic Journal of Oncology

Ability of lymphoscintigraphy to direct sentinel node biopsy in the clinically N0 neck for patients with head and neck squamous cell carcinoma; a prospective study (preliminary results) (p.10001-4)
Serge CAMMILLERI, David LUSSATO, Bruno GUELFUCCI, Frédéric LIEF, Véronique BELLOT, Mariane CHRESTIAN, Michel ZANARET, Jean-Louis BLANC, Olivier MUNDLER

Modulation of Growth Factor response in brain tumors by complex carbohydrates (p.10015-60)
Abdelhadi Rebbaa, Pauline M. Chou, Eric G. Bremer

4-methylthio 2-oxobutanoate transaminase: a specific target for antiproliferative agents (p.10061-79)
Gerard QUASH, Anne Marie ROCH, Carole CHARLOT, Jacqueline CHANTEPIE, Vincent THOMAS, Farid HAMEDI-SANGSARI, Jorge VILA

The Analysis of Correlations between Drug Resistance and Clinical/Laboratory Measures Found in a Group of Children with ALL Treated by ALL-BFM 90 Protocol (p.10080-9)
Vladimir MIHAL, Marian HAJDUCH, Vera NOSKOVA, Anna JANOSTAKOVA, Maria SAFAROVA, Miroslav OREL, Galina KOUZMINA, Jan STARY, Bohuslav BLAZEK, Dagmar POSPISILOVA

Cryopreservation with hydroxyethylstarch (HES) + dimethylsulfoxide (DMSO) gives better results than DMSO alone (p.10097-102)
Gilles CLAPISSON, Cecile SALINAS, Philippe MALACHER, Mauricette MICHALLET, Irene PHILIP, Thierry PHILIP